{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:36:17Z","timestamp":1760524577825,"version":"3.37.3"},"reference-count":34,"publisher":"Informa UK Limited","issue":"15","license":[{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.2217\/fon-2023-0696","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T14:41:42Z","timestamp":1705502502000},"page":"981-995","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Development and validation of algorithms for identifying lines of therapy in multiple myeloma using real-world data"],"prefix":"10.1080","volume":"20","author":[{"given":"Sikander","family":"Ailawadhi","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL32224, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy","family":"Romanus","sequence":"additional","affiliation":[{"name":"Global Evidence & Outcomes, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA02421, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surbhi","family":"Shah","sequence":"additional","affiliation":[{"name":"Real-World Evidence, Evidera\/PPD (part of Thermo\u00a0fisher Scientific), Bethesda, MD20814, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Fraeman","sequence":"additional","affiliation":[{"name":"Real-World Evidence, Evidera\/PPD (part of Thermo\u00a0fisher Scientific), Bethesda, MD20814, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Saragoussi","sequence":"additional","affiliation":[{"name":"Real-World Evidence, Evidera\/PPD (part of Thermo\u00a0fisher Scientific), London,\u00a0W6 8BJ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca Morris","family":"Buus","sequence":"additional","affiliation":[{"name":"Epidemiology and Scientific Affairs, Clinical Development Services Division, Evidera\/PPD (part of Thermo Fisher Scientific), Bethesda, MD20814, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Medical Science and Strategy, Oncology, PPD (part of Thermo Fisher Scientific), Bethesda, MD20814, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dasha","family":"Cherepanov","sequence":"additional","affiliation":[{"name":"Global Evidence & Outcomes, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA02421, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9955-6444","authenticated-orcid":false,"given":"Lois","family":"Lamerato","sequence":"additional","affiliation":[{"name":"Henry Ford Health, Detroit, MI\u00a048202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8833-4544","authenticated-orcid":false,"given":"Ariel","family":"Berger","sequence":"additional","affiliation":[{"name":"Real-World Evidence, Evidera\/PPD (part of Thermo\u00a0fisher Scientific), Bethesda, MD20814, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,1,17]]},"reference":[{"key":"e_1_3_8_3_1","unstructured":"National Comprehensive Cancer Network . NCCN Guidelines: Multiple Myeloma Version 1.2024 (2023). www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1445"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.518"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11050334"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-050522-033815"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.0057"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16309"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0592"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-151235"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.7063"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0805-y"},{"key":"e_1_3_8_13_1","unstructured":"U.S. Food and Drug Administration . Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products. Guidance for Industry. FDA-2021-D-1214 (14 January 2022). www.fda.gov\/media\/154714\/download"},{"key":"e_1_3_8_14_1","unstructured":"U.S. Food and Drug Administration . Real-World Data: Assessing Electronic Health Records and Medical Claims Data to Support Regulatory Decision-Making for Drug and Biological Products. Guidance for Industry. FDA-2020-D-2307 (14 January 2022). www.fda.gov\/media\/152503\/download"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-299487"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-05-647636"},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0049"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04355.x"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04534-8"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2020.1729734"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000182534.19832.83"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.09.002"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40484-016-0081-2"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0591"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-0553"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0647"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocaa028"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-021-00542-0"},{"key":"e_1_3_8_29_1","volume-title":"Poster presented at the 2018 AMCP Managed Care & Specialty Pharmacy Annual Meeting. J Manag Care Pharm. 2018 Apr; 24(4-2):S29.","author":"Parikh R","year":"2018","unstructured":"Parikh R , ClancyZ , CandrilliS , ParikhK. Administrative data algorithms to identify diagnosis and treatment-related measures in patients with multiple myeloma: a validation study. Poster presented at the 2018 AMCP Managed Care & Specialty Pharmacy Annual Meeting. J Manag Care Pharm. 2018 Apr; 24(4-2):S29.Boston, MA (2018).April 25, 2018."},{"key":"e_1_3_8_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5579"},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2004.00315.x"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3247"},{"key":"e_1_3_8_33_1","unstructured":"National Cancer Institute . Cancer Stat Facts: myeloma. https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html (29 March 2022)."},{"key":"e_1_3_8_34_1","unstructured":"National Cancer Institute . Cancer Statistics Review 1975\u20132018: Table A.1 Number of Incidence Cases 2014\u20132018 by Primary Cancer Site Race and Sex (21 SEER Geographic Areas). https:\/\/seer.cancer.gov\/csr\/1975_2018\/browse_csr.php (29 March 2022)."},{"key":"e_1_3_8_35_1","unstructured":"U.S. Food and Drug Administration . FDA approves new therapy for patients with previously treated multiple myeloma. www.fda.gov\/news-events\/press-announcements\/fda-approves-new-therapy-patients-previously-treated-multiple-myeloma (18 November 2021)."},{"key":"e_1_3_8_36_1","unstructured":"U.S. Food and Drug Administration. FDA approves daratumumab for transplant-eligible multiple myeloma. www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-daratumumab-transplant-eligible-multiple-myeloma (3 February 2022)."}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2023-0696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T14:24:07Z","timestamp":1726755847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2023-0696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,17]]},"references-count":34,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.2217\/fon-2023-0696"],"URL":"https:\/\/doi.org\/10.2217\/fon-2023-0696","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"type":"print","value":"1479-6694"},{"type":"electronic","value":"1744-8301"}],"subject":[],"published":{"date-parts":[[2024,1,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-08-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}